Richard W. Palfreyman

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.

Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.